We are live on ! Find out more
PRCT icon

Procept Biorobotics

116 hedge funds and large institutions have $938M invested in Procept Biorobotics in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 33

0.35% more ownership

Funds ownership: 73.2%73.56% (+0.35%)

0% more funds holding

Funds holding: 116116 (0)

0% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 23

29% less funds holding in top 10

Funds holding in top 10: 75 (-2)

31% less capital invested

Capital invested by funds: $1.36B → $938M (-$422M)

64% less call options, than puts

Call options by funds: $4.78M | Put options by funds: $13.4M

Holders
116
Holders Change
Holders Change %
0%
% of All Funds
1.85%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.08%
New
23
Increased
39
Reduced
33
Closed
23
Calls
$4.78M
Puts
$13.4M
Net Calls
-$8.67M
Net Calls Change
-$1.47M

PRCT Hedge Fund Activity: Q1 2023 in Review

116 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q1 2023, worth a combined $938M — down 31% from $1.36B a quarter earlier.

Fund positioning in PRCT was balanced in Q1 2023: 23 funds opened new positions, 23 closed out, 39 added to existing stakes and 33 trimmed.

The largest buyer was ExodusPoint Capital Management, opening a new position worth an estimated $12M. The largest seller was Yale University, exiting entirely with an estimated $23.2M sold.

  • 116 institutional investors held Procept Biorobotics (PRCT) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $938M of Procept Biorobotics stock for Q1 2023, down 31% quarter-over-quarter.
  • 23 funds opened new Procept Biorobotics positions in Q1 2023 and 23 closed out, a net change of 0 holders.
  • The largest Procept Biorobotics buyer in Q1 2023 was ExodusPoint Capital Management, an estimated $12M added.
  • The largest Procept Biorobotics seller in Q1 2023 was Yale University, an estimated $23.2M sold.

Based on aggregated 13F filings for Q1 2023.